Evaluation of 11C-methionine PET as a surrogate endpoint after treatment of grade 2 gliomas

被引:0
作者
Dan Ribom
Marjoleine Schoenmaekers
Henry Engler
Anja Smits
机构
[1] University Hospital,Department of Neuroscience, Neurology
[2] Länssjukhuset,Department of Neurology
[3] Uppsala Imanet AB,undefined
来源
Journal of Neuro-Oncology | 2005年 / 71卷
关键词
low-grade glioma; positron emission tomography; surrogate endpoint;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of the present study was to assess the usefulness of positron emission tomography (PET) as a surrogate endpoint by analysing the uptake variability of 11C-methionine (MET) in follow-up scans.
引用
收藏
页码:325 / 332
页数:7
相关论文
共 201 条
[71]  
Monclus M(undefined)undefined undefined undefined undefined-undefined
[72]  
Salmon I(undefined)undefined undefined undefined undefined-undefined
[73]  
Brotchi J(undefined)undefined undefined undefined undefined-undefined
[74]  
Goldman S(undefined)undefined undefined undefined undefined-undefined
[75]  
Ribom D(undefined)undefined undefined undefined undefined-undefined
[76]  
Eriksson A(undefined)undefined undefined undefined undefined-undefined
[77]  
Hartman M(undefined)undefined undefined undefined undefined-undefined
[78]  
Engler H(undefined)undefined undefined undefined undefined-undefined
[79]  
Nilsson A(undefined)undefined undefined undefined undefined-undefined
[80]  
Långström B(undefined)undefined undefined undefined undefined-undefined